Volume 132, Issue 3, Pages (March 2007)

Slides:



Advertisements
Similar presentations
Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction  Masatoshi Ishigami,
Advertisements

Volume 148, Issue 4, Pages (April 2015)
Volume 153, Issue 3, Pages e7 (September 2017)
Ghazaleh Aram, Theodore M. Bayless, Zong–Ming Chen, Elizabeth A
Volume 152, Issue 4, Pages (March 2017)
Volume 153, Issue 3, Pages e7 (September 2017)
Nonalcoholic steatohepatitis
Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction  Masatoshi Ishigami,
NAFLD, Obesity, and Bariatric Surgery
Volume 133, Issue 1, Pages (July 2007)
Is HCV Infection a Neurologic Disorder?
Outcomes Among Living Liver Donors
Volume 135, Issue 4, Pages (October 2008)
Covering the Cover Gastroenterology
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 149, Issue 2, Pages (August 2015)
Volume 131, Issue 1, Pages (July 2006)
Retinol-Binding Protein 4: A Promising Circulating Marker of Liver Damage in Pediatric Nonalcoholic Fatty Liver Disease  Valerio Nobili, Naim Alkhouri,
Kevin O’Brien, Nadeem Hussain, Bradley A. Warady, David E
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Volume 128, Issue 7, Pages (June 2005)
Targeting the FXR Nuclear Receptor to Treat Liver Disease
Clinical Challenges and Images in GI
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
The Bone Marrow and Liver Fibrosis: Friend or Foe?
Volume 137, Issue 2, Pages (August 2009)
Jean-Michel Pawlotsky  Gastroenterology 
Abstracts from Around the World
Effect of Interferon-Gamma on Hepatic Fibrosis in Chronic Hepatitis B Virus Infection: A Randomized Controlled Study  Hong-Lei Weng, Bao-En Wang, Ji-Dong.
Volume 132, Issue 1, Pages (January 2007)
Volume 149, Issue 2, Pages (August 2015)
Volume 141, Issue 5, Pages e9 (November 2011)
Volume 150, Issue 3, Pages e7 (March 2016)
Treatment of fibrosing cholestatic hepatitis with lamivudine
Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis  Jean–François Dufour, Carl M. Oneta, Jean–Jacques.
Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal Disease  Ferga C. Gleeson, Amy C. Clayton, Lizhi Zhang,
Michel I. Kafrouni, Robert A. Anders, Sumita Verma 
Volume 155, Issue 6, Pages (December 2018)
Mallory–Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C  Mina O. Rakoski, Morton B. Brown, Robert.
Rafael Esteban, Maria Buti  Gastroenterology 
Volume 150, Issue 3, Pages (March 2016)
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Volume 133, Issue 2, Pages (August 2007)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 135, Issue 1, Pages (July 2008)
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Nonalcoholic Steatohepatitis
Volume 125, Issue 2, Pages (August 2003)
This month in Gastroenterology
Suna Yapali, MD, Anna S. Lok, MD, FRCP 
Volume 135, Issue 6, Pages e2 (December 2008)
The Dawning of a New Editorial Board for Gastroenterology
Volume 149, Issue 6, Pages (November 2015)
Volume 142, Issue 4, Pages e6 (April 2012)
Volume 151, Issue 4, Pages (October 2016)
Volume 156, Issue 4, Pages (March 2019)
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Trunk Fat as a Determinant of Liver Disease
Reply Gastroenterology
Characterization of a Splicing Abnormality in Gitelman Syndrome
Shradha Agarwal, Lloyd Mayer  Clinical Gastroenterology and Hepatology 
Electronic Clinical Challenges and Images in GI
Controversies in Liver Transplantation for Hepatitis C
Volume 156, Issue 4, Pages (March 2019)
Volume 135, Issue 6, Pages (December 2008)
Quiz Page September 2014 American Journal of Kidney Diseases
Presentation transcript:

Volume 132, Issue 3, Pages 938-943 (March 2007) Growth Hormone Reverses Nonalcoholic Steatohepatitis in a Patient With Adult Growth Hormone Deficiency  Yutaka Takahashi, Keiji Iida, Kentaro Takahashi, Shiro Yoshioka, Hidenori Fukuoka, Ryoko Takeno, Mari Imanaka, Hitoshi Nishizawa, Michiko Takahashi, Yasushi Seo, Yoshitake Hayashi, Takuma Kondo, Yasuhiko Okimura, Hidesuke Kaji, Riko Kitazawa, Sohei Kitazawa, Kazuo Chihara  Gastroenterology  Volume 132, Issue 3, Pages 938-943 (March 2007) DOI: 10.1053/j.gastro.2006.12.024 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Pretreatment liver biopsy samples (A–D) and posttreatment liver biopsy samples (E–H). Before treatment, typical NASH characteristics were observed. These include marked steatosis (33.5%) with an inflammatory infiltrate and hepatocyte ballooning (H&E staining; original magnification, A and E ×100; B and F ×400) and perisinusoidal and pericellular fibrosis in acinar zone 3 demonstrated by Masson trichrome staining (original magnification, C and G ×100; F and H ×400). In contrast, steatosis was reduced to 7.2% after treatment, inflammatory infiltrate and hepatocyte ballooning disappeared, and fibrosis showed a marked decrease. Gastroenterology 2007 132, 938-943DOI: (10.1053/j.gastro.2006.12.024) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Clinical course during GH-replacement therapy. The daily dose of rhGH was increased gradually. During the treatment, liver dysfunction improved to the normal range. Inflammation and oxidative stress markers such as serum levels of hsCRP and TNF-α, and urine levels of 8OHdG were substantially decreased. Gastroenterology 2007 132, 938-943DOI: (10.1053/j.gastro.2006.12.024) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 An oxidative stress marker, 8OHdG staining, demonstrated that, in pretreatment liver, most of the hepatocytes were positive for the oxidative stress marker (A); however, after treatment, 8OHdG-stained hepatocytes were drastically reduced (B). (C) A negative control. In normal liver, most of the hepatocytes were negative for 8OHdG staining. (D) A positive control. In NASH liver, most of the hepatocytes were positive for 8OHdG staining. Gastroenterology 2007 132, 938-943DOI: (10.1053/j.gastro.2006.12.024) Copyright © 2007 AGA Institute Terms and Conditions